AU2007240983A1 - Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties - Google Patents

Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties Download PDF

Info

Publication number
AU2007240983A1
AU2007240983A1 AU2007240983A AU2007240983A AU2007240983A1 AU 2007240983 A1 AU2007240983 A1 AU 2007240983A1 AU 2007240983 A AU2007240983 A AU 2007240983A AU 2007240983 A AU2007240983 A AU 2007240983A AU 2007240983 A1 AU2007240983 A1 AU 2007240983A1
Authority
AU
Australia
Prior art keywords
less
oil
active agent
composition
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007240983A
Other languages
English (en)
Inventor
Robert Lee
Dinesh Shenoy
Craig Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novavax Inc
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of AU2007240983A1 publication Critical patent/AU2007240983A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2007240983A 2006-04-07 2007-04-03 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties Abandoned AU2007240983A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78991706P 2006-04-07 2006-04-07
US60/789,917 2006-04-07
PCT/US2007/008054 WO2007123790A1 (en) 2006-04-07 2007-04-03 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties

Publications (1)

Publication Number Publication Date
AU2007240983A1 true AU2007240983A1 (en) 2007-11-01

Family

ID=38436994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007240983A Abandoned AU2007240983A1 (en) 2006-04-07 2007-04-03 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties

Country Status (6)

Country Link
EP (1) EP2010149A1 (cg-RX-API-DMAC10.html)
JP (1) JP2009533341A (cg-RX-API-DMAC10.html)
CN (1) CN101466355A (cg-RX-API-DMAC10.html)
AU (1) AU2007240983A1 (cg-RX-API-DMAC10.html)
CA (1) CA2648360A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007123790A1 (cg-RX-API-DMAC10.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504805A (ja) 2005-08-09 2009-02-05 ナノバイオ コーポレーション 抗炎症活性を有するナノエマルジョン組成物
WO2008039864A1 (en) * 2006-09-26 2008-04-03 Novavax, Inc. Emulsion formulations for transdermal delivery of poorly water soluble active agents
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
WO2008157092A1 (en) 2007-06-20 2008-12-24 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
MX2012000105A (es) * 2009-06-30 2012-03-14 Univ Columbia Composiciones antimicrobianas/conservadoras que comprenden extractos botanicos.
AU2012332495B2 (en) 2011-11-03 2017-06-08 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013086094A1 (en) 2011-12-06 2013-06-13 The Trustees Of Columbia University In The City Of New York Broad spectrum natural preservative composition
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
FR2997304B1 (fr) * 2012-10-26 2017-07-07 Isp Investments Inc Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP6248331B2 (ja) * 2013-01-25 2017-12-20 ケミラ ユルキネン オサケイティエＫｅｍｉｒａ Ｏｙｊ 殺生物剤組成物及び水の処理方法
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
CA2990941C (en) * 2015-07-01 2024-02-20 Nissim Garti Delivery systems for propofol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105241793B (zh) * 2015-09-07 2016-10-26 国家纳米科学中心 一种载药胶束形态粒径的测定方法
CN111759823B (zh) * 2015-09-17 2022-12-30 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN113728865B (zh) * 2021-09-24 2022-12-13 广西壮族自治区亚热带作物研究所（广西亚热带农产品加工研究所） 一种澳洲坚果促花保果的综合管理方法
BE1030538B1 (nl) * 2022-05-18 2023-12-19 Bogaert Gina Van Liposomaal preparaat met ingekapselde hormonen, werkwijze voor de productie en gebruik ervan
WO2025054263A2 (en) * 2023-09-06 2025-03-13 The Board Of Regents Of The University Of Texas System Compositions and methods of ent-testosterone for treatment of bacterial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
EP1633322A2 (en) * 2003-06-04 2006-03-15 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof

Also Published As

Publication number Publication date
CA2648360A1 (en) 2007-11-01
WO2007123790A1 (en) 2007-11-01
CN101466355A (zh) 2009-06-24
JP2009533341A (ja) 2009-09-17
EP2010149A1 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
CA2648360A1 (en) Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
Garcia et al. Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils
Pavoni et al. Microemulsions: An effective encapsulation tool to enhance the antimicrobial activity of selected EOs
Bajerski et al. The use of Brazilian vegetable oils in nanoemulsions: an update on preparation and biological applications
US20070264349A1 (en) Nano-structured compositions and methods of making and using the same
US6559189B2 (en) Non-toxic antimicrobial compositions and methods of use
US6635676B2 (en) Non-toxic antimicrobial compositions and methods of use
US8232320B2 (en) Antimicrobial nanoemulsion compositions and methods
US20100226983A1 (en) Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
Manzoor et al. Nanosizing of lavender, basil, and clove essential oils into microemulsions for enhanced antioxidant potential and antibacterial and antibiofilm activities
US8771731B2 (en) Antimicrobial nanoemulsion compositions and methods
AU2002350587A1 (en) Antimicrobial nanoemulsion compositions and methods
EP2633862B1 (en) Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof
US20040043041A1 (en) Antimicrobial compositions and methods of use
US20240082118A1 (en) Topical compositions and methods of preparing the same
Gondim et al. Plant extracts loaded in nanostructured drug delivery systems for treating parasitic and antimicrobial diseases
CN101516358A (zh) 抗病毒组合物以及它们的使用
CN106727324B (zh) 纳米银脂质体及其制备方法和应用
CN102166188A (zh) 一种水包油型樟脑油纳米乳制剂及其制备方法
WO2005030172A1 (en) Antimicrobial nanoemulsion compositions and methods
AU2023270264B2 (en) Topical compositions and methods of preparing the same
US11364199B1 (en) Essential oil nanoemulsion and methods of use thereof
JP2010209109A (ja) 抗微生物ナノエマルジョンの組成物および方法
Pengon et al. Nanoemulsions containing volatile oils as novel antimicrobial for oral health care products.

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application